FlexX-Pharm
contact
impressum
legal notice
print this page
BioSolveIT
The Premier Scientific Solution Provider
Pharmacophore type constraints
FlexX-Pharm allows the user to include constraints similar to pharmacophore type constraints in the docking calculation.

There are two main types of constraints. For the first type, a specific interacting group in the receptor is selected and an interaction between the ligand (any part of the ligand) and this interacting group must be seen in every docking solution. This is called an interaction constraint. The second type of constraint is a spatial constraint. This takes the form of a spherical volume in the active site, and a specified atom or group of atoms from the ligand must lie within the sphere in the docking solution.

Each constraint can be assigned a priority, making it essential or optional in the docking solution, or a logical expression can be used to define which combinations of constraints are allowed in the docking solution. Once defined in the active site, the set of constraints constitutes the pharmacophore in FlexX-Pharm.

FlexX-Pharm is not a standard module in FlexX. In order to access the FlexX-Pharm functionality, an extra license key is required.

status & availability
FlexX-Pharm is available as a modular extension of FlexX for
SGI Irix
Microsoft Windows
Linux 32bit
Linux 64bit (significantly faster).
Additional operating systems are available on request.

If you would like to evaluate FlexX-Pharm, or lease the module from us, you need to take the following steps:

  1. contact us to obtain a license using the license request form.
  2. download the FlexX software package from our download page.
contact
If you need more information or you require help or support using FlexX-Pharm, please pose your question in the support center. Alternatively, send us your message or suggestions to FlexX-Pharm@BioSolveIT.de.

Your feedback is very valuable and enables us to further develop and improve our software!


m this link leads back to mother tool FlexX
Last modified Wednesday, 22. Aug 2007 14:38 CEST by WebMaster